WallStSmart

Apple Inc. (AAPL)vsCheck-Cap Ltd. (MBAI)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

Apple Inc. generates 19993175% more annual revenue ($466.82B vs $2.33M). AAPL leads profitability with a 27.6% profit margin vs 21.7%. MBAI trades at a lower P/E of 0.4x. AAPL earns a higher WallStSmart Score of 67/100 (B-).

AAPL

Strong Buy

67

out of 100

Grade: B-

Growth: 6.7Profit: 10.0Value: 3.7Quality: 6.5
Piotroski: 7/9Altman Z: 2.42

MBAI

Hold

46

out of 100

Grade: D+

Growth: 4.3Profit: 9.0Value: 6.7Quality: 4.5
Piotroski: 2/9Altman Z: -29.22

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AAPL6 strengths · Avg: 9.5/10
Market CapQuality
$5.01T10/10

Mega-cap, among the largest globally

Return on EquityProfitability
119.9%10/10

Every $100 of equity generates 120 in profit

Operating MarginProfitability
32.6%10/10

Strong operational efficiency at 32.6%

Free Cash FlowQuality
$31.91B10/10

Generating 31.9B in free cash flow

Profit MarginProfitability
27.6%9/10

Keeps 28 of every $100 in revenue as profit

Revenue GrowthGrowth
16.4%8/10

16.4% revenue growth

MBAI5 strengths · Avg: 9.4/10
P/E RatioValuation
0.4x10/10

Attractively priced relative to earnings

Return on EquityProfitability
120.5%10/10

Every $100 of equity generates 120 in profit

Debt/EquityHealth
0.0010/10

Conservative balance sheet, low leverage

Profit MarginProfitability
21.7%9/10

Keeps 22 of every $100 in revenue as profit

Operating MarginProfitability
21.3%8/10

Strong operational efficiency at 21.3%

Areas to Watch

AAPL3 concerns · Avg: 2.7/10
P/E RatioValuation
39.4x4/10

Premium valuation, high expectations priced in

PEG RatioValuation
2.712/10

Expensive relative to growth rate

Price/BookValuation
47.4x2/10

Trading at 47.4x book value

MBAI4 concerns · Avg: 3.8/10
Price/BookValuation
17.4x4/10

Trading at 17.4x book value

Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$31.58M3/10

Smaller company, higher risk/reward

Comparative Analysis Report

WallStSmart Research

Bull Case : AAPL

The strongest argument for AAPL centers on Market Cap, Return on Equity, Operating Margin. Profitability is solid with margins at 27.6% and operating margin at 32.6%. Revenue growth of 16.4% demonstrates continued momentum.

Bull Case : MBAI

The strongest argument for MBAI centers on P/E Ratio, Return on Equity, Debt/Equity. Profitability is solid with margins at 21.7% and operating margin at 21.3%.

Bear Case : AAPL

The primary concerns for AAPL are P/E Ratio, PEG Ratio, Price/Book.

Bear Case : MBAI

The primary concerns for MBAI are Price/Book, Revenue Growth, EPS Growth.

Key Dynamics to Monitor

AAPL profiles as a growth stock while MBAI is a value play — different risk/reward profiles.

AAPL carries more volatility with a beta of 1.07 — expect wider price swings.

AAPL is growing revenue faster at 16.4% — sustainability is the question.

AAPL generates stronger free cash flow (31.9B), providing more financial flexibility.

Bottom Line

AAPL scores higher overall (67/100 vs 46/100), backed by strong 27.6% margins and 16.4% revenue growth. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Apple Inc.

TECHNOLOGY · CONSUMER ELECTRONICS · USA

Apple Inc. is an American multinational technology company that specializes in consumer electronics, computer software, and online services. Apple is the world's largest technology company by revenue (totalling $274.5 billion in 2020) and, since January 2021, the world's most valuable company. As of 2021, Apple is the world's fourth-largest PC vendor by unit sales, and fourth-largest smartphone manufacturer. It is one of the Big Five American information technology companies, along with Amazon, Google, Microsoft, and Facebook.

Visit Website →

Check-Cap Ltd.

TECHNOLOGY · SOFTWARE - INFRASTRUCTURE · USA

Check-Cap Ltd., a clinical stage medical diagnostics company, focuses on capsule-based screening technology products. The company is headquartered in Isfiya, Israel.

Want to dig deeper into these stocks?